Canopy Growth Corporation
medical marijuana company based in Smiths Falls, Ontario
WEED Toronto Stock Exchange
ISIN CA1380351009 SEC CIK 1737927 LEI 529900CSD7NH1UBC9X07
Follow Canopy Growth
Weekly email: filings, results
Revenue, last quarter
CAD 81.4M
+22% vs same quarter last year
Net income
−CAD 40.7M
−717.5% vs same quarter last year
EPS, diluted
−CAD 0.10
−400% vs same quarter last year
Operating cash flow
−CAD 12.6M
+30.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | CAD 284.6M | −CAD 262.9M |
| FY25 | CAD 269M | −CAD 508.9M |
| FY24 | CAD 297.1M | −CAD 693.7M |
| FY23 | CAD 333.3M | −CAD 3.3B |
| FY22 | CAD 475.7M | −CAD 310M |
| FY21 | CAD 546.6M | −CAD 1.7B |
| FY20 | CAD 398.8M | −CAD 1.3B |
| FY19 | CAD 226.3M | −CAD 736.3M |
| FY18 | CAD 77.9M | −CAD 67.3M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 24.5% | −56.8% | −92.4% |
| FY25 | 29.6% | −43.5% | −189.2% |
| FY24 | 27.2% | −77% | −233.4% |
| FY23 | −19.1% | −789.3% | −983.7% |
| FY22 | −39.4% | −214.2% | −65.2% |
| FY21 | 12.2% | −227.5% | −319.2% |
| FY20 | −7.9% | −418.5% | −331.3% |
| FY19 | 12.5% | −281.6% | −325.3% |
| FY18 | 42.3% | −153.4% | −86.3% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −CAD 69.1M |
| FY25 | −CAD 176.6M |
| FY24 | −CAD 285.4M |
| FY23 | −CAD 566.7M |
| FY22 | −CAD 582.5M |
| FY21 | −CAD 630.2M |
| FY20 | −CAD 1.5B |
| FY19 | −CAD 1.2B |
| FY18 | −CAD 257.5M |
| FY17 | - |
- Canopy Growth
- Healthcare median
Show the numbers
| Year | Canopy Growth | Healthcare median |
|---|---|---|
| FY26 | −92.4% | −11.1% |
| FY25 | −189.2% | −30.6% |
| FY24 | −233.4% | −47% |
| FY23 | −983.7% | −58% |
| FY22 | −65.2% | −80.4% |
| FY21 | −319.2% | −71.9% |
| FY20 | −331.3% | −62.2% |
| FY19 | −325.3% | −46.3% |
| FY18 | −86.3% | −49.6% |
| FY17 | - | −45.9% |